This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Accelerate oligonucleotide and peptide products from early discovery to late-stage development & commercialization.

How the Right-Size Oligosynthesizer is Crucial to Manufacturing Productivity

Share this article

George Flores, Technical Solutions Manager at Asahi Kasei Bioprocess, discusses the potential of oligonucleotides in vaccine and therapeutic development and the challenges in large-scale manufacturing at the TIDES USA conference in San Diego, California.

Share this article

Upcoming event

TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum

19 - 21 Mar 2024, Kyoto, Japan

THE ONLY EVENT IN ASIA FOR OLIGO, PEPTIDE, mRNA, GENOME EDITING & DELIVERY EXPERTS TO EXCHANGE STRATEGIES TO ACCELERATE MOLECULES TO MARKET

Go to site